,,ii  #aaeth ,,congress  #b;d ,session  
,s4 #cggj  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,december #ah1 
#bjah ,mr4 ,booker introduced the       
following bill2 which was read twice and
 referred to the ,committee on ,finance 
,a ,,bill  ,to amend title ,,xi of the  
,social ,security ,act to expand the    
scope of transparency reporting         
requirements related to the ownership or
 investment interests of health care    
providers and others1 and to increase   
the penalties associated with violating 
such requirements4  #a4 ,short title    
,this ,act may be cited as the ,medicaid
 ,drug ,decisions ,transparency ,act4   
#b4 ,ownership or investment interest   
transparency for health care providers  
and others  7a7 ,in general ,section    
#aabh;,g of the ,social ,security ,act  
7#db ,u4,s4,c4 #acbj;a-#g;h7 is         
amended-- 7#a7 in subsection 7b7--  7,a7
 in paragraph 7#a77;,a71 by striking    
#aj1jjj and inserting #bj1jjj2  7,b7 in 
paragraph 7#a77;,b71 by striking        

#aej1jjj and inserting #cjj1jjj2  7,c7  
in paragraph 7#b77;,a71 by striking     
#ajj1jjj and inserting #bjj1jjj2 and    
7,d7 in paragraph 7#b77;,b71 by striking
 #a1jjj1jjj and inserting #b1jjj1jjj2   
7#b7 in subsection 7d77#b71 by adding at
 the end the following sentence3        
,beginning with calendar year #bjba1    
such report shall include a separate    
summary of the information submitted    
under subsection 7a7 during the         
preceding year with respect to the      
covered recipients described in clause  
7vii7 of subsection 7e77#f77;,a742 and  
7#c7 in subsection 7e77#f77;,a71 by     
adding at the end the following3  7vi7  
,a pharmacist 7as defined in section    
#hjd7;a77#b7 of the ,federal ,food1     
,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4
 #chd7;a77#b774  7vii7 ,an individual or
 entity with decision-making authority  
over the formulary or preferred drug    
list of a ,state plan 7or a waiver of a 
plan7 under title ,,xix1 including an   
individual or entity that participates  

in the establishment of such a drug     
formulary or preferred drug list or in  
the drug utilization review process for 
such a plan or waiver1 such as a member 
of a ,state drug use review board       
described in section #aibg4  4  7b7     
,effective date ,the amendments made by 
this section shall take effect on       
,january #a1 #bjbj1 and shall apply to  
information required to be submitted    
under section #aabh;,g of the ,social   
,security ,act 7#db ,u4,s4,c4           
#acbj;a-#g;h7 on or after such date4    
#c4 ,state drug use review board        
membership transparency ,section        
#aibg7;g77#c77;,b7 of the ,social       
,security ,act 7#db ,u4,s4,c4           
#acifr-#h7;g77#c77;,b77 is amended--    
7#a7 by redesignating clauses 7i7       
through 7iv7 as subclauses 7,i7 through 
7,,iv7 and moving such subclauses 7as so
 redesignated7 #b ems to the right2     
7#b7 in the matter preceding subclause  
7,i7 7as so redesignated71 by striking  
,the membership and inserting the       

following3  7i7 ,in general ,the        
membership  2  7#c7 in the last         
sentence1 by striking ,the membership   
and inserting the following3  7ii7      
,requirement ,the membership  2 and     
7#d7 by adding at the end the following3
  7iii7 ,publication of membership ,each
 ,state shall publish a list of the     
,,dur ,board members on an ,internet web
 site in a format that is clear and     
understandable and regularly shall      
update the list with any changes to such
 membership4  4